샘플 요청 목록

 카트 문의
시장보고서
상품코드
1761142

세계의 지카바이러스 검사 시장

Zika Virus Testing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 158 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

지카바이러스 검사 세계 시장은 2030년까지 3억 1,450만 달러에 달할 전망

2024년에 2억 2,450만 달러로 추정되는 지카바이러스 검사 세계 시장은 분석 기간인 2024-2030년에 CAGR 5.8%로 성장하여 2030년에는 3억 1,450만 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 분자 검사는 CAGR 6.4%를 기록하며 분석 기간 종료시에는 1억 9,240만 달러에 달할 것으로 예측됩니다. 혈청학적 검사 분야의 성장률은 분석 기간 동안 CAGR 4.9%로 추정됩니다.

미국 시장은 5,870만 달러로 추정, 중국은 CAGR 9.9%로 성장 예측

미국의 지카바이러스 검사 시장은 2024년에 5,870만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간 2024년부터 2030년까지 CAGR 9.9%로 성장하여 2030년에는 예측 시장 규모 7,550만 달러에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 2.2%와 5.9%로 예측됩니다. 유럽에서는 독일이 CAGR 2.8%로 성장할 것으로 예측됩니다.

세계의 지카바이러스 검사 시장 - 주요 동향과 촉진요인 정리

지카바이러스의 확산은 효과적인 검사 솔루션의 필요성을 어떻게 촉진하고 있는가?

모기 매개 감염병인 지카바이러스의 유행은 특히 열대 및 아열대 지역에서 심각한 공중보건 문제로 대두되고 있습니다. 소두증과 같은 심각한 선천성 기형 및 기타 신경학적 합병증을 유발할 수 있는 지카바이러스 감염이 증가함에 따라 효과적인 검사 솔루션의 필요성이 강조되고 있습니다. 라틴아메리카, 카리브해, 동남아시아, 아프리카 일부 국가에서는 다수의 감염 사례가 보고되고 있으며, 정확하고 신속한 진단 검사에 대한 긴급한 수요가 증가하고 있습니다. 전 세계 보건 당국과 조직은 바이러스 확산을 방지하고 잠재적인 발병을 관리하기 위해 조기 진단에 중점을 두고 있습니다. 그 결과, 지카바이러스 검사는 질병 감시 프로그램의 중요한 요소가 되어 분자 분석, 혈청학적 검사, 현장 진단 등 다양한 진단 검사에 대한 수요를 증가시키고 있습니다.

어떤 기술 혁신이 지카바이러스 검사 능력을 향상시키고 있는가?

기술의 발전은 지카바이러스 검사 능력을 크게 향상시켜 보다 정확하고 신속하며 신뢰할 수 있는 진단을 가능하게 하고 있습니다. 실시간 중합효소 연쇄 반응(RT-PCR) 검사와 같은 분자진단의 혁신은 높은 민감도와 특이성으로 인해 지카바이러스 검출의 새로운 표준이 되고 있습니다. 이 검사는 감염 후 며칠 이내에 바이러스 RNA를 검출할 수 있어 적시에 개입할 수 있는 중요한 정보를 제공합니다. 또한, 뎅기열과 치쿤구니아와 같은 여러 플라비 바이러스를 동시에 검사할 수 있는 멀티플렉스 분석법이 개발되어 의료 서비스 제공자들 사이에서 인기를 얻고 있습니다. 또한, 신속진단 검사(RDT) 및 휴대용 핵산 증폭검사(NAAT)와 같은 POCT(Point-of-care testing) 솔루션은 사용이 간편하고, 가격이 저렴하며, 발병 대응에 필수적인 신속한 검사 결과를 제공할 수 있기 때문에 자원이 제한된 환경에서 널리 사용되고 있습니다.

규제 당국의 승인과 자금 조달 이니셔티브가 지카바이러스 검사 시장에 어떤 영향을 미치고 있는가?

지카바이러스 검사 시장 형성에는 규제 당국의 승인과 자금 조달 이니셔티브가 중요한 역할을 하고 있습니다. 미국 식품의약국(FDA)과 세계보건기구(WHO)와 같은 정부 기관은 지카바이러스에 대한 새로운 진단 검사의 승인 및 검증에 적극적으로 참여하고 있으며, 필요한 민감도와 특이도 기준을 충족하는지 확인하고 있습니다. 또한, 긴급사용승인(EUA)이 가능해짐에 따라 혁신적인 진단 도구의 시장 진입이 가속화되고 있습니다. 자금 측면에서는 정부기관, 비정부기구(NGO), 민간단체의 투자 증가가 첨단 지카바이러스 검사 기술의 개발과 상용화에 큰 도움이 되고 있습니다. 이러한 경제적 인센티브는 R&D 활동을 촉진하고, 전 세계 보건 문제를 해결하기 위해 보다 강력하고 확장 가능한 검사 솔루션의 사용을 촉진하고 있습니다.

지카바이러스 검사 시장의 성장은 몇 가지 요인으로 인해 발생합니다.

지카바이러스 검사 시장의 성장은 지카바이러스 감염 증가, 분자진단 기술 및 현장 진단 기술의 발전, 헬스케어 인프라 및 질병 감시 투자 증가 등 여러 요인에 의해 주도되고 있습니다. 특히 지카바이러스와 다른 플라비 바이러스가 공존하는 유행 지역에서는 집단 발병 시 신속하고 정확한 진단의 필요성이 큰 원동력이 되고 있습니다. 멀티플렉스 분석 및 휴대용 NAAT와 같은 기술 발전은 검사 능력을 향상시키고, 원격지 및 자원이 제한된 지역으로의 시장 진입을 확대하고 있습니다. 또한, 규제 당국의 승인과 정부의 재정 지원 이니셔티브는 지카바이러스 검사의 가용성과 접근성을 높이고 있습니다. 조기 진단과 예방의 중요성에 대한 의료진과 일반 대중의 인식이 높아지면서 시장 성장에 기여하고 있으며, 지카바이러스 검사는 전 세계 보건 안보의 중요한 요소로 자리 잡고 있습니다.

부문

유형(분자 검사, 혈청 검사), 최종사용자(조사기관, 진단 연구소, 병원·진료소)

조사 대상 기업 사례(총 11개사)

  • Biocan Diagnostics
  • Chembio Diagnostic Systems, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Quest Diagnostics, Inc.
  • SD Biosensor, Inc.

AI 통합

당사는, 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범에 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.07.07

Global Zika Virus Testing Market to Reach US$314.5 Million by 2030

The global market for Zika Virus Testing estimated at US$224.5 Million in the year 2024, is expected to reach US$314.5 Million by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Molecular Testing, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$192.4 Million by the end of the analysis period. Growth in the Serological Testing segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$58.7 Million While China is Forecast to Grow at 9.9% CAGR

The Zika Virus Testing market in the U.S. is estimated at US$58.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$75.5 Million by the year 2030 trailing a CAGR of 9.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Zika Virus Testing Market - Key Trends & Drivers Summarized

How Is the Rising Prevalence of Zika Virus Driving the Need for Effective Testing Solutions?

The outbreak of the Zika virus, a mosquito-borne disease, has emerged as a significant public health challenge, particularly in tropical and subtropical regions. The increasing prevalence of Zika virus infections, which can lead to severe birth defects such as microcephaly and other neurological complications, has underscored the need for effective testing solutions. Countries in Latin America, the Caribbean, Southeast Asia, and parts of Africa have reported numerous cases, driving urgent demand for accurate and rapid diagnostic tests. Healthcare authorities and organizations worldwide are emphasizing early diagnosis to prevent the spread of the virus and manage potential outbreaks. Consequently, Zika virus testing has become a critical component of disease surveillance programs, boosting the demand for a variety of diagnostic tests, including molecular assays, serological tests, and point-of-care diagnostics.

What Technological Innovations Are Enhancing Zika Virus Testing Capabilities?

Technological advancements are significantly enhancing the capabilities of Zika virus testing, enabling more accurate, rapid, and reliable diagnosis. Innovations in molecular diagnostics, such as real-time polymerase chain reaction (RT-PCR) tests, have set a new standard for Zika detection due to their high sensitivity and specificity. These tests can detect the viral RNA within days of infection, providing crucial information for timely intervention. Additionally, the development of multiplex assays that can simultaneously test for multiple flaviviruses, such as dengue and chikungunya, is gaining traction among healthcare providers. Point-of-care testing (POCT) solutions, such as rapid diagnostic tests (RDTs) and portable nucleic acid amplification tests (NAATs), are also becoming popular in resource-limited settings due to their ease of use, affordability, and ability to deliver quick results, which are essential for outbreak control.

How Are Regulatory Approvals and Funding Initiatives Influencing the Zika Virus Testing Market?

Regulatory approvals and funding initiatives play a crucial role in shaping the Zika virus testing market. Government agencies, such as the U.S. Food and Drug Administration (FDA) and the World Health Organization (WHO), have been actively involved in approving and validating new diagnostic tests for Zika virus, ensuring they meet the necessary sensitivity and specificity criteria. Additionally, the availability of emergency use authorizations (EUAs) has accelerated the market entry of innovative diagnostic tools during outbreaks. On the funding side, increased investment from government bodies, non-governmental organizations (NGOs), and private entities has significantly supported the development and commercialization of advanced Zika virus testing technologies. These financial incentives are driving research and development activities, promoting the availability of more robust and scalable testing solutions to address global health concerns.

The Growth in the Zika Virus Testing Market Is Driven by Several Factors

The growth in the Zika virus testing market is driven by several factors, including the increasing prevalence of Zika infections, advancements in molecular and point-of-care diagnostic technologies, and rising investments in healthcare infrastructure and disease surveillance. The need for rapid and accurate diagnosis during outbreaks is a significant driver, particularly in endemic regions where Zika co-circulates with other flaviviruses. Technological advancements, such as multiplex assays and portable NAATs, are enhancing testing capabilities and expanding the market's reach to remote and resource-limited areas. Additionally, regulatory approvals and government funding initiatives are boosting the availability and accessibility of Zika virus tests. The growing awareness among healthcare providers and the general public about the importance of early diagnosis and prevention is also contributing to market growth, making Zika virus testing a vital component of global health security.

SCOPE OF STUDY:

The report analyzes the Zika Virus Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Molecular Testing, Serological Testing); End-Use (Research Institutes, Diagnostic Laboratories, Hospitals & Clinics)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 11 Featured) -

  • Biocan Diagnostics
  • Chembio Diagnostic Systems, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Quest Diagnostics, Inc.
  • SD Biosensor, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • Zika Virus Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising incidence of Zika virus infections drives demand for advanced testing solutions
    • Growing government initiatives and public health programs boost market growth
    • Technological advancements in diagnostic testing kits enhance market opportunities
    • Increasing adoption of point-of-care testing kits to improve accessibility
    • Development of multiplex assays for simultaneous detection fuels market demand
    • Expansion of laboratory infrastructure in emerging markets spurs market growth
    • Growing awareness among populations about Zika virus testing enhances market potential
    • Strategic collaborations between research institutions and diagnostic companies propel innovation
    • Increasing focus on developing rapid and cost-effective diagnostic solutions drives market
    • Growing investments in research and development for novel testing methods support market expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Zika Virus Testing Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Zika Virus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Zika Virus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Zika Virus Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Molecular Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Molecular Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Molecular Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Serological Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Serological Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Serological Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • JAPAN
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • CHINA
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • EUROPE
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Zika Virus Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Zika Virus Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Zika Virus Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • FRANCE
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • GERMANY
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Zika Virus Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Zika Virus Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Zika Virus Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • INDIA
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Zika Virus Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Zika Virus Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Zika Virus Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Zika Virus Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Zika Virus Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Zika Virus Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • AFRICA
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제